Mesenchymal stem/stromal cells alleviate early‐stage pulmonary fibrosis in a uPAR‐dependent manner
- 18 July 2024
- journal article
- research article
- Published by Wiley in Cell Biology International
- Vol. 48 (11) , 1714-1730
Abstract
Pulmonary fibrosis, a debilitating lung disorder characterised by excessive fibrous tissue accumulation in lung parenchyma, compromises respiratory function leading to a life‐threatening respiratory failure. While its origins are multifaceted and poorly understood, the urokinase system, including urokinase‐type plasminogen activator (uPA) and its receptor (uPAR), plays a significant role in regulating fibrotic response, extracellular matrix remodelling, and tissue repair. Mesenchymal stem/stromal cells (MSCs) hold promise in regenerative medicine for treating pulmonary fibrosis. Our study aimed to investigate the potential of MSCs to inhibit pulmonary fibrosis as well as the contribution of uPAR expression to this effect. We found that intravenous MSC administration significantly reduced lung fibrosis in the bleomycin‐induced pulmonary fibrosis model in mice as revealed by MRI and histological evaluations. Notably, administering the MSCs isolated from adipose tissue of uPAR knockout mice (Plaur‐/‐ MSCs) attenuated lung fibrosis to a lesser extent as compared to WT MSCs. Collagen deposition, a hallmark of fibrosis, was markedly reduced in lungs treated with WT MSCs versus Plaur‐/‐ MSCs. Along with that, endogenous uPA levels were affected differently; after Plaur‐/‐ MSCs were administered, the uPA content was specifically decreased within the blood vessels. Our findings support the potential of MSC treatment in attenuating pulmonary fibrosis. We provide evidence that the observed anti‐fibrotic effect depends on uPAR expression in MSCs, suggesting that uPAR might counteract the uPA accumulation in lungs.Keywords
Funding Information
- Russian Science Foundation (19‐75‐30007)
This publication has 73 references indexed in Scilit:
- Mesenchymal stromal cells enhance self-assembly of a HUVEC tubular network through uPA-uPAR/VEGFR2/integrin/NOTCH crosstalkBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2022
- Urokinase receptor deficiency results in EGFR-mediated failure to transmit signals for cell survival and neurite formation in mouse neuroblastoma cellsCellular Signalling, 2020
- Downregulation of uPAR promotes urokinase translocation into the nucleus and epithelial to mesenchymal transition in neuroblastomaJournal of Cellular Physiology, 2020
- The fibrogenic actions of the coagulant and plasminogen activation systems in pulmonary fibrosisThe International Journal of Biochemistry & Cell Biology, 2018
- Diversity and functional evolution of the plasminogen activator systemBiomedicine & Pharmacotherapy, 2018
- Regulatory Effects of Urokinase on Mesenchymal Stromal Cell Migration, Proliferation, and Matrix Metalloproteinase SecretionBulletin of Experimental Biology and Medicine, 2016
- Concise Review: The Bystander Effect: Mesenchymal Stem Cell-Mediated Lung RepairStem Cells, 2016
- Urokinase type plasminogen activator mediates Interleukin-17-induced peripheral blood mesenchymal stem cell motility and transendothelial migrationBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2015
- Fibrinolysis and the control of blood coagulationBlood Reviews, 2015
- Role of the Plasminogen and MMP Systems in Wound Healing2003